| Application no. and date | 01933832.6 (espacenet) (Federated) (European Patent Register), 20010412 | | Patent/reg. no. and date | DK/EP 1274402, 20090805 | | Publication date | 20030115 | | Priority no. and date | GB 0009522, 20000419 | | EP pub. no. and date |
EP 1274402 20030115 | | Effective date | | | Applicant/owner | GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No.2), Knockbrack, Dungarvan
IE-County Waterford, IE | | Applicant ref. no. | 153378 | | Inventor | CHAN, Shing Yue,
GlaxoSmithKline, 1500 Littleton Road
Parsipanny, NJ 07054, US,
GRATTAN, Timothy James,
GlaxoSmithKline, St George's Avenue,
Weybridge
Surrey KT13 0DE, GB,
SENGMANEE, Bounkhiene,
c/o GlaxoSmithKline, 82 Hughes Avenue
Ermington, NSW 2114, AU | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/167 (2006.01) , A61K 9/24 (2006.01) | | Title | Farmaceutisk sammensætning til kontrolleret frigivelse af paracetamol | | Int. application no. | EP2001004302 | | Int. publication no. | WO2001080834 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
